In its upcoming report, Carlyle Group (CG) is predicted by Wall Street analysts to post quarterly earnings of $0.92 per share, reflecting an increase of 46% compared to the same period last year. Revenues are forecasted to be $1.03 billion, representing a year-over-year increase of 36.6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 1.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during ...

Wall Street witnessed an impressive bull run for the past 15 months. The rally was led by growth stocks, especially, technology stocks. Consequently, the tech-heavy Nasdaq Composite Index took the lead role in enabling U.S. stock markets to resume their northward journey after a highly disappointing 2022.Moreover, the ongoing tech rally was led by a massive thrust toward artificial intelligence (AI), especially generative AI. The rapid penetration of digital technologies and the Internet worldwide during th ...

Carlyle Group (CG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Individ ...

New York, New York, April 15, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as Administrative Agent and Lead Left Arranger for a unitranche facility supporting the refinancing of Acentra Health ("Acentra"), a portfolio company of Carlyle. Acentra is a leading provider of technology products and services to government healthcare agencies that are essential to administering Medicaid, Medicare and other health programs at the federal and state level, including claims processing, enrollment and data ...

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.Cash flow can come from bond interest, interest from other types of investments, and of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a me ...

Szepy Rallying stock markets around the world and a stabilizing bond market are tailwinds for asset managers. What's more, while capital market activity has been weak, there is optimism on Wall Street that dealmaking and private equity trends may improve in the second half of 2024. I reiterate my buy rating on Carlyle Group (NASDAQ:CG). I see more upside ahead, though shares are not a steal of a deal anymore. Furthermore, price action remains healthy, as the peak from a few years ago could be in play soon. ...

Esken is to wind itself up after agreeing to dispose of Southend Airport, its main asset, to private equity group Carlyle, sending its share price crashing by two-thirds. In a statement, Esken said it had agreed to the recapitalisation proposal from Carlyle, its main lender, as fighting it would have been potentially destructive to all shareholders. Ratifying the recapitalisation through the courts will take several months, Esken said, but once complete it will delist its shares with any return to sharehold ...

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("CSL") (NASDAQ:CGBD) today announced that Justin Plouffe has been named President, Chief Executive Officer (CEO), and member of the Board of Directors, effective immediately. This appointment follows the resignation of Aren LeeKong from the Company to pursue other opportunities professionally. Mr. Plouffe is a Managing Director and the Deputy Chief Investment Officer for Global Credit at Carlyle. He focuses on investing across Carly ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

London, UK and New York, USA, February 29, 2024 - Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ:CG), today announced a strategic development financing agreement with Gilead Sciences. The financing agreement will provide up to $210 million in funding to support select clinical studies of Trodelvy® (sacituzumab govitecan-hziy), within non-small cell lung cancer. As part of the agreement, Launch Therapeutics, a clinical development company ba ...